A detailed history of Hillman CO transactions in Nautilus Biotechnology, Inc. stock. As of the latest transaction made, Hillman CO holds 200,000 shares of NAUT stock, worth $454,000. This represents 0.28% of its overall portfolio holdings.

Number of Shares
200,000
Previous 200,000 -0.0%
Holding current value
$454,000
Previous $598,000 1.67%
% of portfolio
0.28%
Previous 0.28%

Shares

1 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2021

Jul 21, 2021

BUY
$9.04 - $14.19 $1.81 Million - $2.84 Million
200,000 New
200,000 $2.02 Million

Others Institutions Holding NAUT

About Nautilus Biotechnology, Inc.


  • Ticker NAUT
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 124,663,000
  • Market Cap $283M
  • Description
  • Nautilus Biotechnology, Inc., a development stage life sciences company, engages in creating a platform technology for quantifying and unlocking the complexity of the proteome. It develops Nautilus Platform, a proteomics platform that includes end-to-end solution comprised of instruments, consumables, and software analysis. The company was found...
More about NAUT
Track This Portfolio

Track Hillman CO Portfolio

Follow Hillman CO and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Hillman CO, based on Form 13F filings with the SEC.

News

Stay updated on Hillman CO with notifications on news.